Diagnosis of Tuberculosis in HIV Co-infected Individuals: Current Status, Challenges and Opportunities for the Future.

作者: P. Méndez-Samperio

DOI: 10.1111/SJI.12567

关键词:

摘要: Tuberculosis (TB) remains one of the most important causes death among people co-infected with human immunodeficiency virus (HIV). The diagnosis TB challenging in HIV individuals, due to a high frequency smear-negative disease and rates extrapulmonary TB. Accurate, ease use rapid active are critical World Health Organization (WHO) End Strategy by 2050. Traditional laboratory techniques do not provide accurate results effectively manage patients. Over last decade, molecular methods have provided significant steps fight against However, many patients access these diagnostic tests. Given costs closely related confirming patients, an overtreatment for is used this patient population. Nowadays, estimated US $8 billion year required treatment, which very compared making strategy improve current This review focuses on advances diagnosing emphasis HIV-associated Also discussed main challenges that need be overcome improving adequate initial HIV-positive

参考文章(74)
JHK Chen, KKK She, T-C Kwong, O-Y Wong, GKH Siu, C-C Leung, K-C Chang, C-M Tam, P-L Ho, VCC Cheng, K-Y Yuen, W-C Yam, None, Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 34, pp. 1827- 1832 ,(2015) , 10.1007/S10096-015-2419-5
Maria S Ramirez, German M Traglia, David L Lin, Tung Tran, Marcelo E Tolmasky, None, Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-Negatives: the Klebsiella pneumoniae Paradigm Microbiology spectrum. ,vol. 2, pp. 1- 15 ,(2014) , 10.1128/MICROBIOLSPEC.PLAS-0016-2013
Paul K Drain, Nigel J Garrett, The arrival of a true point-of-care molecular assay-ready for global implementation? The Lancet Global Health. ,vol. 3, ,(2015) , 10.1016/S2214-109X(15)00186-2
Timothy M Walker, Thomas A Kohl, Shaheed V Omar, Jessica Hedge, Carlos Del Ojo Elias, Phelim Bradley, Zamin Iqbal, Silke Feuerriegel, Katherine E Niehaus, Daniel J Wilson, David A Clifton, Georgia Kapatai, Camilla LC Ip, Rory Bowden, Francis A Drobniewski, Caroline Allix-Béguec, Cyril Gaudin, Julian Parkhill, Roland Diel, Philip Supply, Derrick W Crook, E Grace Smith, A Sarah Walker, Nazir Ismail, Stefan Niemann, Tim EA Peto, None, Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infectious Diseases. ,vol. 15, pp. 1193- 1202 ,(2015) , 10.1016/S1473-3099(15)00062-6
Prabha Desikan, Sputum smear microscopy in tuberculosis: is it still relevant? Indian Journal of Medical Research. ,vol. 137, pp. 442- 444 ,(2013)
Christian Wejse, Tuberculosis elimination in the post Millennium Development Goals era. International Journal of Infectious Diseases. ,vol. 32, pp. 152- 155 ,(2015) , 10.1016/J.IJID.2014.11.020
David C. Young, Emilie Layre, Shih-Jung Pan, Asa Tapley, John Adamson, Chetan Seshadri, Zhongtao Wu, Jeffrey Buter, Adriaan J. Minnaard, Mireia Coscolla, Sebastien Gagneux, Richard Copin, Joel D. Ernst, William R. Bishai, Barry B. Snider, D. Branch Moody, In Vivo Biosynthesis of Terpene Nucleosides Provides Unique Chemical Markers of Mycobacterium tuberculosis Infection Chemistry & Biology. ,vol. 22, pp. 516- 526 ,(2015) , 10.1016/J.CHEMBIOL.2015.03.015
Philip M Ashton, Satheesh Nair, Tim Dallman, Salvatore Rubino, Wolfgang Rabsch, Solomon Mwaigwisya, John Wain, Justin O'Grady, MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island Nature Biotechnology. ,vol. 33, pp. 296- 300 ,(2015) , 10.1038/NBT.3103
James E. Galagan, Genomic insights into tuberculosis Nature Reviews Genetics. ,vol. 15, pp. 307- 320 ,(2014) , 10.1038/NRG3664